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Abstract: Parkinson Disease (PD) is a neurodegenerative disorder affecting motor system. It is a 
chronic progressive disorder leading to long standing disability.  
Objective: To study the clinical presentation of PD among Sudanese patients seen at Elshaab 
Teaching Hospital during the period from May2004-April 2008. 
Methodology: In this descriptive prospective, cross sectional hospital based study, 94 patients were 
studied using standardized questionnaire including history and clinical examination.  
Result: The total number diagnosed to have PD was 94 patients. Male to female ratio was found to 
be1.5:1.Common age group affected was 70-80 years (24.47%).The common presenting symptom 
was found to be poverty of movement (93.6%) followed by tremor (82.98%). On neurological 
examination; rigidity, dyskinesia and festinate gait were the common signs. Primitive reflexes were 
found in significant number of patients. Idiopathic PD was found to be the common type (75.53%). 
Of the side effects of benzhexol, 66.67% of our patients developed dry mouth. Postural hypotension 
was seen in 10.42% of the patients who were taking levodopa.  
Conclusion: The clinical presentations of our patients does not differ from what was mentioned in 
the literature                                   
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arkinson disease (PD) is a 
neurodegenerative disorder affecting 
motor system. It was first described in 
1817 by James Parkinson, a British physician, 
who published a paper in what he called it 
shaking palsy1,2. PD is a chronic progressive 
disease, with an incidence of 20 new cases per 
100000 people and a prevalence of 200 cases 
per 100000 in the United States. PD seems to 
be running in families in some cases but 95% 
of cases are sporadic3, 4.  
PD is age specific, it affects 1% of population 
over the age of 60, which is the average age 
of onset, and it was suggested that the disease 
may be time locked to certain age related 
changes in the nervous system. However, 
early onset disease below the age of 40 occurs 
in 5-10% of cases, suggesting that in addition 
to any changes related to age there are other 
contributory factors to the disease.  
PD has equal sex distribution5, 6. There is no 
social, economic or geographical variation but 
some studies showed that African American 
Correspondence: Dr. Abbasher Hussien . Department 
of medicine, University of Khartoum -Sudan 
 and Asian are less likely affected than 
Caucasians. Idiopathic PD account   for 85% 
of cases7, 8. In idiopathic PD there is loss of 
dopamine producing cells, the dead cells 
contain Lewy bodies9, 10. A number of other 
disorders and some drugs can cause 
parkinsonian features. 
 PD diagnosis is based on history and clinical 
examination. Investigations are requested if 
there is suspicious of underlying causes. PD is 
not a curable disease; treatment is to relief the 
symptoms.                                    
 Objective: To study the clinical presentation 
of PD among Sudanese patients.  
Methodology: This is a descriptive 
prospective cross sectional hospital based 
study. It was conducted at Elshaab Teaching 
Hospital, which is a 200 bedded tertiary 
hospital. There are two neurological units 
with 50 beds, two intensive care units and an 
intermediate one. The study population 
included patients with PD referred to the 
hospital in the period from May2004-April 
2008.All of the patients were Sudanese and 
newly diagnosed. They gave their verbal 
P
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consent to participate in the study. The study 
was approved by the local ethics committee. 
A detailed history and clinical examinations 
were performed by the authors. The physical 
signs were grouped into general, systemic and 
neurological. Diagnosis of PD is clinically 
based on primary and secondary symptoms. 
Investigations were requested to rule out other 
diseases if needed. Patients were treated 
medically and followed up monthly. Data 
were analyzed, then the results expressed in 
form of figures, tables and graphs using SPSS 
programme. 
Result: The total number diagnosed to have 
PD was 94 patients, 59.6% out of these were 
males with male to female ratio of 1.5:1.  The 
age groups 70-79 years, 60-69years and 50-59 
years represent the majority of patients 
(24.47%, 22.3% and 18.09% respectively), 
while the younger ages 40-49 years, 30-39 
years, 20-29 years, 10-19 years and 1-9 years 
constitute smaller percentages (7.45%, 
10.64%, 6.38%, 8.5% and 1.06% 
respectively). Very old patients (80-89 years) 
form 1.06% of patients. House wives 
constituted 34.04% of patients. Geographical 
distribution showed that 50% of our patients 
were from Khartoum region, 30.85% from 
central Sudan, 9.57% from western Sudan, 
8.5% from northern Sudan and 1.06% from 
eastern Sudan. Family history of similar 
condition was found in 11.7%. In the past 
medical history 17.02% of our patients had 
febrile illness that preceded the Parkinsonian 
feature, 8.5% had jaundice, 3.19% had trauma 
and 1.06% had Syphilis. 12.77% used to 
consume alcohol. The common presenting 
symptoms were illustrated in table (1) .   
 
Table 1: Presenting symptoms among 94 
Sudanese patients with Parkinson disease 
 
Some of our patients had associated diseases. 
Hypertension, diabetes mellitus, 
cerebrovascular disease, disc prolapse and 
epilepsy were seen in 15.97%, 5.32%, 5.32%, 
3.19% and 2.13% of patients respectively.  
Ischemic heart disease, goitre, asthma, 
gallstone, breast lump, chronic renal failure, 
benign prostatic hypertrophy, renal stone, 
coeliac, gastritis and congenital ptosis were 
found in 1.06% each. The primitive reflexes 
observed and the Parkinsonian features were 
shown in table (2) 
 
Table 2: The primitive reflexes and clinical 
findings among 94 Sudanese patients with 
Parkinson disease 
 
Signs No % 
Glabellar reflex 56 59.57 
Bouting reflex 22 23.4 
Palmomental reflex 14 14.89 
Grasp reflex 15 15.96 
Tremor 78 82.98 
Cog wheel 79 84.04 
Lead pipe 69 73.4 
Dyskinesia 69 73.4 
Festinant Gait 73 77.66 
 
All patients had normal higher functions apart 
from three patients; two (2.13%) of them 
were mentally retarded.  
Kayser Fleischer ring was found in 6.38%, 
3.19% patients had facial nerve palsy and 
1.06% had gaze palsy. Dystonia was detected 
in 6.38 % (3.19% due to Wilson disease, 
2.13% due to Levodopa side effect and 1.06% 
associated with Idiopathic Parkinson. 
Examination of the upper and lower limbs 
showed that 44.68% had wasting and 1.06% 
had deformity. All patients had normal power 
except 12.77% whose power ranged from 
grade 3 to 4. Reflexes were normal in 58.51% 
and hyperreflexia was observed in 41.49%. 
Nine patients (9.57%) were bed ridden and 12 
patients (12.77%) had normal gait. Postural 
hypotension was observed in 14.89% of the 
patients, in most of them it is due to 
Levodopa therapy (9.6%). Causes of 
Parkinson disease were found as follow: 
Idiopathic in 75.53% of the patients, Wilson 
Symptoms NO % 
Poverty of movement 88 93.6 
Tremor 78 82.98 
Excessive salivation 28 29.79 
Excessive sweating 27 28.7 
Constipation 45 47.87 
Dysphagia 18 19.15 
Dysartheria 45 47.87 
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disease in 12.77%, vascular in 7.45%, supra 
nuclear palsy in 2.13%, Multi system Atrophy 
in 1.06% and drug induced in 1.06% of the 
patients.                                                              
All patients were treated medically, 
Benzhexol was used by 30.85% of the 
patients, Levodopa used by (18.09%) of the 
patients, 32.98% of the patients received 
Benzhexol and Levodopa and 18.09% 
received other drugs like Selegiline and 
Bromocriptine. Side effects of Benzhexol and 
Levodopa were shown in table (3&4).                                                              
 
Table 3: Side effects of Benzhexol among 60 
Sudanese patients with Parkinson disease 
 
 No % 
Dry mouth 40 66.67 
Blurring of vision 20 33.33 
Urine retention 2 3.33 
Constipation 12 20 
Confusion 14 23.33 
 
 
Table 4: Side effects of Levodopa among 48 
Sudanese patients with Parkinson disease 
 no % 
Nausea 8 16.67 
Vomiting 8 16.67 
Postural hypotension 5 10.42 
Palpitation 4 8.44 
Dystonia 2 4.17 
Axial rigidity 1 2.08 




The study showed that the vast majority of 
patients were from Khartoum and central 
Sudan (80.5%). The large population and the 
feasibility of diagnosis in this part of the 
country had probably played a central role in 
that. Males were affected more than females 
with male to female ratio of 1.5:1 this is 
similar to other reports11. The fact that males 
are exposed to risk factors that cause 
Parkinson disease more than females may 
partially explains that12. The peak incidence 
of PD was found to be in the age group 70 -80 
years (24.47%). This is similar to the findings 
of Witjas et al, but it differs from others13. 
The late presentation of our patients could be 
behind these differences12, 14. This also holds 
true for the duration of the disease before 
presentation, however, miss diagnosis is 
another contributory factor12, 13. Most patients 
had idiopathic Parkinson (75.53%) and that 
goes with what was mentioned in the 
literature15. A considerable number of our 
patients had Wilson disease (12.77%). 
Atherosclerosis was found in 7.45% of our 
patients, which is similar to literature, but it 
differed from a study done in Spain15. Drug 
induced PD accounted for 1.06% which is far 
less than the 22% reported elsewhere. There is 
no clear reason for that, however, non 
compliance to treatment especially 
hypertensive and psychotic patients might 
have contributed to that15. Common 
presenting symptoms in our study were found 
to be poverty of movement (93.6%) and 
tremors (82.98%), this is similar to the reports 
from Saudi Arabia and elsewhere11, 13. Other 
presenting symptoms include constipation 
which was detected in 47.87%, this is similar 
to study done by Witjas and et al (40%) and 
differed from a study done in Sudia Arabia by 
Al Bunyan (63%)11, 13.     
Excessive sweating, excessive salivation and 
dysphagia were less common than reports 
from Saudi Arabia and other places11, 13. The 
stage, activity of the disease and the 
differences in daily habit, emotional support 
and style of life appeared to play a role in 
these differences11, 13. Dysartheria was 
detected in (47.87%) of the patients13. The 
small number of patients in this study could 
explain the relatively small percentage 
(11.7%) of patients with family history 
compared to that found in Denmark14.  There 
is significant number of patients who had past 
history of jaundice, fever, trauma, some 
patients were used to take alcohol and one 
patient had past history of syphilis, all these 
are well known causes of parkinsonism. The 
primitive reflexes, signs of brain atrophy, 
which has a well known recognized 
association with PD had appeared at the 
expected ages in our patients. Cog wheel 
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rigidity and lead pipe rigidity were seen in a 
high percentage in our patients, similar to a 
report from Saudi Arabia11.  Dyskinesia was 
less in our patients compared to   Al Bunyan’s 
finding11.  Festinant gait was found in 77.66% 
which is different from the results reported by 
Witjas et al. Part of these neurological 
differences can be explain by the late 
presentation of our patients. Cranial nerves 
involvement in our patients is due to vascular 
causes, three patients had facial palsy and 
they had repeated attacks of CVA. Dystonia 
was reported in few numbers of patients 
unlike what was mentioned in the literature4, 5. 
The small doses of Levodopa used by our 
patients is probably behind that, this also 
holds true for the decreased incidence of on-
off phenomena, postural hypotension  and 
other side effects of the drug among our 
patients6-10.  
Conclusion: PD is common among male than 
female. The most affected age group was 
found to be 70-80s. Idiopathic PD was found 
to be the most common type. Family history 
was found in a minority of our patients.  
There were significant numbers of patients 
with Wilson's disease and febrile illness 
preceding the parkinsonian feature. Few 
patients were bedridden. Primitive reflexes 
were found in significant number of patients. 
Although our findings were generally similar 
to literature; there are some few differences. 
Our patients had minimal side effects of the 
drugs.                                                           
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